Pharming Group N.V. (PHAR) Statistics & Valuation Metrics - Stocknear

Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
13.79
-1.01 (-6.82%)
At close: Sep 26, 2025, 3:59 PM
14.00
1.52%
After-hours: Sep 26, 2025, 07:08 PM EDT

Pharming Statistics

Share Statistics

Pharming has 67.43M shares outstanding. The number of shares has increased by 0.29% in one year.

67.43M
0.29%
0.29%
0.01%
67.07M
72
0.7%

Short Selling Information

The latest short interest is 11.04K, so 0.02% of the outstanding shares have been sold short.

11.04K
0.02%
0.02%
1

Valuation Ratios

The PE ratio is -62.97 and the forward PE ratio is -740. Pharming's PEG ratio is -10.14.

-62.97
-740
2.26
2.5
3.03
-258.67
-10.14
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pharming.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.49.

3.77
3.02
0.49
6.65
-41.84
-0.99

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$735.64K
$-26.35K
404
0.74
0.64

Taxes

2.43M
-29.61%

Stock Price Statistics

The stock price has increased by 62.43% in the last 52 weeks. The beta is 0.59, so Pharming's price volatility has been higher than the market average.

0.59
62.43%
12.85
10.28
48.57
10,304

Income Statement

In the last 12 months, Pharming had revenue of 297.2M and earned -10.64M in profits. Earnings per share was -0.15.

297.2M
261.8M
-8.62M
-10.64M
16.32M
245K
-0.15
Full Income Statement

Balance Sheet

The company has 54.94M in cash and 108.42M in debt, giving a net cash position of -53.47M.

54.94M
108.42M
-53.47M
-275.49M
446.26M
157.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.79M and capital expenditures -796K, giving a free cash flow of -2.59M.

-1.79M
-796K
-2.59M
-0.04
Full Cash Flow Statement

Margins

Gross margin is 88.09%, with operating and profit margins of -2.9% and -3.58%.

88.09%
-2.9%
-2.76%
-3.58%
5.49%
-2.9%
-0.87%

Dividends & Yields

PHAR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PHAR is $37, which is 168.3% higher than the current price. The consensus rating is "Buy".

$37
168.3%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

3.13
5